Prijeđi na sadržaj

Cilazapril

Izvor: Wikipedija
Cilazapril
Kekulé, stereo, skeletal formula of cilazapril ((1S,9S)-9-[(2S)-2-yl]amin,-1-carbox)
IUPAC ime
Identifikacija
CAS registarski broj 88768-40-5 DaY
PubChem[1][2] 56330
40467985 (1R,9S)-(2S)-butilamino izomer
ChemSpider[3] 50831 DaY
UNII 8Q9454114Q DaY
DrugBank DB01340
KEGG[4] D07699
ChEMBL[5] CHEMBL515606 DaY
ATC code C09AA08
Jmol-3D slike Slika 1
Svojstva
Molekulska formula C22H31N3O5
Molarna masa 417.5 g mol−1
log P 2,212
pKa 2,285
Baznost (pKb) 11,712
Farmakologija
Načini upotrebe Oralno
Legalni status

POM(UK)

 DaY (šta je ovo?)   (verifikuj)

Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje (25 °C, 100 kPa) materijala

Infobox references

Cilazapril je inhibitor angiotenzin konvertujućeg enzima (ACE inhibitor) koji se koristi za tretiranje hipertenzije i zatajenja srca.[6][7] Neka od prodajnih imena ovog leka su: Inhibace, Vascace i Dynorm.[8][9]

Osobine

[uredi | uredi kod]
Osobina Vrednost
Broj akceptora vodonika 7
Broj donora vodonika 2
Broj rotacionih veza 9
Particioni koeficijent[10] (ALogP) -0,7
Rastvorljivost[11] (logS, log(mol/L)) -3,5
Polarna površina[12] (PSA, Å2) 99,2

Reference

[uredi | uredi kod]
  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.  edit
  4. Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H. 
  5. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.  edit
  6. Szucs, T. (1991). „Cilazapril. A review”. Drugs 41 Suppl 1: 18–24. PMID 1712267. 
  7. Jasek, W, ur. (2007) (German). Austria-Codex (2007/2008 izd.). Vienna: Österreichischer Apothekerverlag. ISBN 978-3-85200-181-4. 
  8. Drugs.com: Cilazapril
  9. Cilazapril monograph. Lexi-Comp Online, Lexi-Drugs Online, Lexi-Comp Inc. Hudson, OH. Available at: [1] Arhivirano 2004-11-16 na Wayback Machine-u. Accessed October 5, 2008.
  10. Ghose, A.K., Viswanadhan V.N., and Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A 102: 3762-3772. DOI:10.1021/jp980230o. 
  11. Tetko IV, Tanchuk VY, Kasheva TN, Villa AE. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488-1493. DOI:10.1021/ci000392t. PMID 11749573.  edit
  12. Ertl P., Rohde B., Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714-3717. DOI:10.1021/jm000942e. PMID 11020286.  edit

Literatura

[uredi | uredi kod]

Vanjske veze

[uredi | uredi kod]
pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy